ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.570
+0.010 (0.64%)
At close: May 26, 2026, 4:00 PM EDT
1.630
+0.060 (3.82%)
After-hours: May 26, 2026, 5:21 PM EDT
ProQR Therapeutics Employees
ProQR Therapeutics had 187 employees as of December 31, 2025. The number of employees increased by 21 or 12.34% compared to the previous year.
Employees
187
Change (1Y)
21
Growth (1Y)
12.34%
Revenue / Employee
$84,276
Profits / Employee
-$281,071
Market Cap
165.42M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 187 | 21 | 12.34% |
| Dec 31, 2024 | 166 | 10 | 6.07% |
| Dec 31, 2023 | 157 | 26 | 20.28% |
| Dec 31, 2022 | 130 | -51 | -28.30% |
| Dec 31, 2021 | 182 | 31 | 20.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Heron Therapeutics | 128 |
| Tenaya Therapeutics | 70 |
| Korro Bio | 49 |
| OnKure Therapeutics | 45 |
| Spero Therapeutics | 25 |
| TuHURA Biosciences | 22 |
| Galectin Therapeutics | 9 |
PRQR News
- 14 days ago - ProQR Announces First Quarter 2026 Operating and Financial Results - GlobeNewsWire
- 14 days ago - ProQR Therapeutics Earnings release: Q1 2026 - Filings
- 15 days ago - ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform - GlobeNewsWire
- 22 days ago - ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 - GlobeNewsWire
- 26 days ago - ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors - GlobeNewsWire
- 6 weeks ago - ProQR Therapeutics management to meet with Cantor Fitzgerald - TheFly
- 6 weeks ago - ProQR Therapeutics management to meet with Oppenheimer - TheFly
- 6 weeks ago - ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event - GlobeNewsWire